Revvity | PKI - Ebitda


Revvity reported $272.91M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
Align Technology USD 260.87M 77.03M Dec/2025
Bio Techne USD 116.71M 13.29M Mar/2026
Bio-Rad Laboratories USD 983.8M 1.36B Dec/2025
Bruker USD 110M 101.6M Mar/2026
Celltrion KRW 17.79B 356.77B Dec/2025
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 9.34B 440M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Illumina USD 469M 137M Dec/2025
Intuitive Surgical USD 1.09B 165.5M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Laboratory Of America USD 605.6M 17.5M Mar/2026
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Organigram Holdings CAD 5.26M 884K Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Pharma Mar EUR 2.71M 42.25M Mar/2026
Qiagen NV USD 249.69M 56.53M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Quidel USD 108.7M 44.6M Mar/2026
Repligen USD 40.01M 469K Mar/2026
Revvity USD 272.91M 24M Mar/2026
Sartorius EUR 267.3M 10.1M Mar/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Tilray USD 8.36M 1.82M Sep/2025
Waters USD 380.97M 85.83M Dec/2025
Zealand Pharma A/S -727.47M 285.54M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026